Kwality Pharmaceuticals Limited (BOM:539997)

India · Delayed Price · Currency is INR

3,590.75

+146.00 (4.24%)

At close: Aug 17, 2026

Kwality Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	5,540	5,031	3,702	3,072	2,510	4,562
Revenue Growth	37.94%	35.90%	20.52%	22.36%	-44.97%	73.42%
Gross Profit	2,586	2,371	1,820	1,492	1,375	2,511
Operating Income	1,173	1,005	637.51	484.53	466.8	1,627
Net Income	810.45	673.46	398.45	237.96	193.72	1,200
Earnings Per Share	78.10	64.90	38.36	22.93	18.67	115.64
EPS Growth	86.80%	69.19%	67.27%	22.84%	-83.86%	692.22%

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Export	2,498	1,954	1,383	1,196	2,996
India	2,533	1,748	1,687	1,284	1,564
Mozambique	0.24	-	-	1.93	1.62
Total	5,031	3,702	3,072	2,510	4,562

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	35.92	35.92	147.55	59.44	73.63	129.51
Total Debt	1,307	1,307	1,124	981.19	902.64	631.92
Net Cash (Debt)	-1,271	-1,271	-976.9	-921.75	-829	-502.41
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-122.51	-122.51	-94.15	-88.83	-79.89	-48.42

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	165.86	527.18	429.83	413.82	605.97
Capital Expenditures	-	-446.02	-232.93	-298.41	-476.73	-551.52
Free Cash Flow	-	-280.15	294.25	131.42	-62.92	54.45
Free Cash Flow Growth	-	-	123.91%	-	-	64.69%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	46.68%	47.13%	49.16%	48.56%	54.75%	55.04%
Operating Margin	21.18%	19.97%	17.22%	15.77%	18.59%	35.66%
Pretax Margin	19.22%	17.79%	14.62%	10.12%	10.19%	35.42%
Profit Margin	14.63%	13.39%	10.76%	7.75%	7.72%	26.30%
FCF Margin	-	-5.57%	7.95%	4.28%	-2.51%	1.19%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 17, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	44.10	20.13	22.63	17.85	16.47	5.02
P/FCF Ratio	-	-	30.65	32.33	-	110.54
PS Ratio	6.45	2.69	2.44	1.38	1.27	1.32